2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with biochanin a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexi, X; Alexis, MN; Aligiannis, N; Fokialakis, N; Meligova, AK; Mitakou, S; Pratsinis, H; Siriani, D | 1 |
| Dolkart, O; Gigi, R; Katzburg, S; Salai, M; Sharon, O; Somjen, D; Stern, N | 1 |
2 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and biochanin a
| Article | Year |
|---|---|
Ester and carbamate ester derivatives of Biochanin A: synthesis and in vitro evaluation of estrogenic and antiproliferative activities.
Topics: Antineoplastic Agents; Carbamates; Cell Line, Tumor; Cell Proliferation; Esters; Genistein; Humans; Trifolium | 2012 |
Rivaroxaban, a direct inhibitor of the coagulation factor Xa interferes with hormonal-induced physiological modulations in human female osteoblastic cell line SaSO2.
Topics: Alkaline Phosphatase; Anticoagulants; Cell Line; Cell Proliferation; Creatine Kinase; DNA; Enzyme Activation; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Factor Xa; Factor Xa Inhibitors; Female; Genistein; Ginsenosides; Humans; Isoflavones; Morpholines; Nitriles; Osteoblasts; Osteogenesis; Parathyroid Hormone; Rivaroxaban; RNA, Messenger; Sapogenins; Thiophenes; Vitamin D | 2013 |